Advanced HER2-positive Breast Cancer or Gastric Cancer
1 clinical trials · Condition
◉ Watch Advanced HER2-positive Breast Cancer or Gastric Cancer
| Record | Firm | Date |
|---|---|---|
| Phase I Study LJM716 Combined With Trastuzumab in Patients With HER2 Overexpressing Metastatic Breast or Gastric Cancer (NCT01602406) | Novartis Pharmaceuticals | 2012-09-21 |
Track Advanced HER2-positive Breast Cancer or Gastric Cancer automatically
Every clearance here is in the API, with alerts when new ones post.